Vanguard Long-Term Bond ETF (BLV): Price and Financial Metrics ETF
BLV Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $69.63 | 52-week high | $76.87 |
| Prev. close | $70.52 | 52-week low | $67.45 |
| Day low | $69.57 | Volume | 752,500 |
| Day high | $70.60 | Avg. volume | 726,268 |
| 50-day MA | $71.48 | Dividend yield | 4.93% |
| 200-day MA | $71.78 |
BLV Stock Price Chart Interactive Chart >
Vanguard Long-Term Bond ETF (BLV) ETF Bio
The investment objective of the Vanguard Long-Term Bond ETF seeks to track the performance of the Barclays U.S. Long Government/Credit Float Adjusted Index. This index includes all medium and larger issues of U.S. government, investment-grade corporate, and investment-grade international dollar-denominated bonds that have maturities of greater than 10 years and are publicly issued.
BLV ETF Info
| Issuer | Vanguard Group |
| Expense Ratio | 0.04% |
| Underlying Index | Bloomberg Barclays U.S. Long Government/Credit Float Adjusted Index |
| Asset Class | Fixed Income |
| Sector | Long-Term Bond ETFs |
| Assets Under Management (AUM) | 5.64B |
| Net Asset Value (NAV) | $70.47 |
| Options? | Yes |
| Total Holdings | 3062 |
BLV Top Holdings
| Symbol | Company | % of Total |
| United States Treasury Note/Bond | 1.47% | |
| MKTLIQ | 0.3% | |
| Anheuser-Busch Cos LLC / Anheuser-Busch InBev Worldwide Inc | 0.2% | |
| United States Treasury Note/Bond | 0.2% | |
| Goldman Sachs Group Inc/The | 0.14% | |
| CVS Health Corp | 0.13% | |
| Pfizer Investment Enterprises Pte Ltd | 0.12% | |
| United States Treasury Note/Bond | 0.12% | |
| AT&T Inc | 0.11% | |
| Warnermedia Holdings Inc | 0.11% |
BLV Price Returns
| 1-mo | -0.98% |
| 3-mo | -6.94% |
| 6-mo | -0.67% |
| 1-year | -2.48% |
| 3-year | -24.02% |
| 5-year | -14.36% |
| YTD | -2.36% |
| 2023 | 7.35% |
| 2022 | -26.95% |
| 2021 | -2.89% |
| 2020 | 15.47% |
| 2019 | 18.99% |
BLV Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||